• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠转移肝切除术前肝脂肪变性的处理:叙述性综述及病例说明。

Clearing Steatosis Prior to Liver Surgery for Colorectal Metastasis: A Narrative Review and Case Illustration.

机构信息

Division of Abdominal Surgery, Department of Surgery, Geneva University Hospitals, University of Geneva, 1205 Geneva, Switzerland.

Department of Pathology and Immunology, University of Geneva, 1205 Geneva, Switzerland.

出版信息

Nutrients. 2022 Dec 15;14(24):5340. doi: 10.3390/nu14245340.

DOI:10.3390/nu14245340
PMID:36558499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9785595/
Abstract

Over recent years, non-alcoholic fatty liver disease (NAFLD) has become the most common liver disorder in the developed world, accounting for 20% to 46% of liver abnormalities. Steatosis is the hallmark of NAFLD and is recognized as an important risk factor for complication and death after general surgery, even more so after liver resection. Similarly, liver steatosis also impacts the safety of live liver donation and transplantation. We aim to review surgical outcomes after liver resection for colorectal metastases in patients with steatosis and discuss the most common pre-operative strategies to reduce steatosis. Finally, as illustration, we report the favorable effect of a low-caloric, hyper-protein diet during a two-stage liver resection for colorectal metastases in a patient with severe steatosis.

摘要

近年来,非酒精性脂肪性肝病(NAFLD)已成为发达国家最常见的肝脏疾病,占肝脏异常的 20%至 46%。脂肪变性是 NAFLD 的标志,被认为是普外科手术后并发症和死亡的重要危险因素,在肝切除术后更是如此。同样,肝脂肪变性也会影响活体肝捐赠和移植的安全性。我们旨在回顾脂肪变性患者结直肠转移行肝切除术后的手术结果,并讨论减少脂肪变性最常用的术前策略。最后,作为说明,我们报告了在一位严重脂肪变性患者行两阶段肝切除治疗结直肠转移时,低热量高蛋白饮食的良好效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72da/9785595/e04fe7771330/nutrients-14-05340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72da/9785595/e04fe7771330/nutrients-14-05340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72da/9785595/e04fe7771330/nutrients-14-05340-g001.jpg

相似文献

1
Clearing Steatosis Prior to Liver Surgery for Colorectal Metastasis: A Narrative Review and Case Illustration.结直肠转移肝切除术前肝脂肪变性的处理:叙述性综述及病例说明。
Nutrients. 2022 Dec 15;14(24):5340. doi: 10.3390/nu14245340.
2
Non-Alcoholic Fatty Liver Disease May Be a Risk Factor for Liver Metastasis After Radical Surgery for Colorectal Cancer: A Retrospective Study.非酒精性脂肪性肝病可能是结直肠癌根治术后肝转移的危险因素:一项回顾性研究。
J Gastrointest Cancer. 2024 Jun;55(2):932-939. doi: 10.1007/s12029-024-01042-6. Epub 2024 Mar 19.
3
Hepatic steatosis in patients undergoing resection of colorectal liver metastases: A target for prehabilitation? A narrative review.结直肠肝转移切除患者的肝脂肪变性:是预康复的靶点吗?一篇叙述性综述。
Surg Oncol. 2019 Sep;30:147-158. doi: 10.1016/j.suronc.2019.07.007. Epub 2019 Aug 2.
4
Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study.肝脂肪变性和剩余肝体积定量在预测结直肠转移瘤肝切除术后肝功能障碍和并发症中的作用:一项初步研究。
HPB (Oxford). 2012 Mar;14(3):194-200. doi: 10.1111/j.1477-2574.2011.00426.x. Epub 2012 Jan 16.
5
Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy.术前化疗后接受结直肠癌肝转移切除术的有脂肪变性和无脂肪变性患者的等效生存率。
Eur J Surg Oncol. 2014 Nov;40(11):1436-44. doi: 10.1016/j.ejso.2014.07.040. Epub 2014 Aug 21.
6
Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.肝细胞脂肪变性、体重指数与结直肠肝转移患者行肝切除术的长期预后。
Eur J Surg Oncol. 2010 Jan;36(1):52-7. doi: 10.1016/j.ejso.2009.09.004. Epub 2009 Oct 29.
7
The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasis.术前磁共振波谱分析在结直肠癌肝转移患者肝脂肪性肝炎评估中的价值。
J Hepatol. 2012 Mar;56(3):640-6. doi: 10.1016/j.jhep.2011.10.006. Epub 2011 Oct 23.
8
The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer.非酒精性脂肪性肝病进展为结直肠癌肝转移的风险。
Expert Rev Gastroenterol Hepatol. 2019 Dec;13(12):1169-1180. doi: 10.1080/17474124.2019.1697231. Epub 2019 Nov 29.
9
Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.结直肠癌肝转移患者在肝切除术前接受结直肠癌化疗不会对围手术期结局产生不利影响。
J Surg Oncol. 2007 Jan 1;95(1):22-7. doi: 10.1002/jso.20632.
10
Omega-3 Fatty Acids Protect Fatty and Lean Mouse Livers After Major Hepatectomy.ω-3 脂肪酸可保护大肝切除术后肥胖和非肥胖小鼠的肝脏。
Ann Surg. 2017 Aug;266(2):324-332. doi: 10.1097/SLA.0000000000001968.

引用本文的文献

1
Trimming the fat myth: adipose tissue's role in liver regeneration.消除脂肪误区:脂肪组织在肝脏再生中的作用
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):727-731. doi: 10.21037/hbsn-24-181. Epub 2024 Jul 16.
2
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences.从非酒精性脂肪性肝病到非酒精性脂肪性肝炎:了解非酒精性肝病的范围及其后果。
Heliyon. 2024 Apr 25;10(9):e30387. doi: 10.1016/j.heliyon.2024.e30387. eCollection 2024 May 15.

本文引用的文献

1
The impact of hepatic steatosis on outcomes of colorectal cancer patients with liver metastases: A systematic review and meta-analysis.肝脂肪变性对结直肠癌肝转移患者预后的影响:一项系统评价和荟萃分析。
Front Med (Lausanne). 2022 Sep 8;9:938718. doi: 10.3389/fmed.2022.938718. eCollection 2022.
2
A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease.一项针对非酒精性脂肪性肝病患者的微生物组网络对运动和饮食干预反应的随机对照试验。
Nat Commun. 2022 May 10;13(1):2555. doi: 10.1038/s41467-022-29968-0.
3
NASH and the Gut Microbiome: Implications for New Therapies.
非酒精性脂肪性肝炎与肠道微生物群:对新疗法的启示
Clin Liver Dis (Hoboken). 2022 Jan 28;19(3):97-100. doi: 10.1002/cld.1170. eCollection 2022 Mar.
4
Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections.巨噬细胞免疫代谢调控:抗感染的新策略
Front Immunol. 2022 Jan 26;13:780839. doi: 10.3389/fimmu.2022.780839. eCollection 2022.
5
Elective Surgery in Adult Patients with Excess Weight: Can Preoperative Dietary Interventions Improve Surgical Outcomes? A Systematic Review.超重成人患者的择期手术:术前饮食干预能否改善手术结局?系统评价。
Nutrients. 2021 Oct 25;13(11):3775. doi: 10.3390/nu13113775.
6
Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents.肠道微生物群在儿童和青少年非酒精性脂肪性肝病调控中的作用
Front Nutr. 2021 Jun 25;8:700058. doi: 10.3389/fnut.2021.700058. eCollection 2021.
7
Perioperative omega-3 fatty acids for liver surgery: A meta-analysis of randomized controlled trials.围手术期ω-3 脂肪酸在肝外科手术中的应用:一项随机对照试验的荟萃分析。
Medicine (Baltimore). 2021 Jul 9;100(27):e25743. doi: 10.1097/MD.0000000000025743.
8
Arginine-dependent immune responses.精氨酸依赖的免疫应答。
Cell Mol Life Sci. 2021 Jul;78(13):5303-5324. doi: 10.1007/s00018-021-03828-4. Epub 2021 May 26.
9
The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials.白藜芦醇在肝脏疾病中的作用:从体外到临床试验的综合综述。
Nutrients. 2021 Mar 13;13(3):933. doi: 10.3390/nu13030933.
10
Successful Outcome of Bariatric Surgery in Living Donor Liver Transplant Recipients With Multidisciplinary Approach: A Preliminary Experience.多学科方法治疗活体肝移植受者肥胖症手术的成功结果:初步经验
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):144-148. doi: 10.1016/j.jceh.2020.05.008. Epub 2020 Jun 6.